The additional inclusion of SBP, diabetes, log-UACR, serum albumin, and Hb (model 7) resulted in substantially different probabilities, with the predicted probability of ESKF onset at 3 years reduced by 7.6% in patient A and increased by 11.9% in patient B. The gene discussed is GSTM1; the disease is diabetes mellitus.